Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-01-12
2000-02-01
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31405
Patent
active
060203595
ABSTRACT:
A Pharmaceutical composition in a form suitable for parenteral administration comprising a solution of the glycine antagonist (E)-3-[2-phenylcarbamoyl) ethenyl]-4,6-dichloroindole-2-carboxylic, acid or a physiologically acceptable salt thereof, in an isotonic sugar solution containing a water miscible organic solvent for the compound, said formulation having a pH within the range of 7 to 9.
REFERENCES:
patent: 5106847 (1992-04-01), Salituro et al.
patent: 5886018 (1999-03-01), Lodi et al.
Remington's Pharmaceutical Sciences (15th ed.) 1975, p. 759.
Lodi Andrea
Rossato Maria Teresa
Glaxo Wellcome SpA
Spivack Phyllis G.
LandOfFree
Pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-937901